Sarah Ponto Shubeck MD
Breast
Assistant Professor, Department of Surgery, University of Chicago
Join to view full profile
5841 S Maryland AveChicago, IL 60637
Phone+1 888-824-0200
Dr. Shubeck is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Sarah Shubeck is a general surgeon based in Chicago, IL, with a subspecialty in breast surgery. She completed her surgical residency at the University of Michigan and a fellowship in Breast Surgical Oncology at Memorial Sloan Kettering Cancer Center. Dr. Shubeck's expertise includes breast reconstruction, cosmetic and minimally invasive breast surgeries. She has contributed to several publications, including studies on breast cancer presentation, breast-conserving surgery, and predictors for chemotherapy response in early-stage breast cancer patients. Her research in the field is recognized, with several works being cited by other professionals.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Breast Surgical Oncology, 2020 - 2021
University of MichiganResidency, Surgery, 2013 - 2020
University of MichiganHealth and Healthcare Research, 2016 - 2017
University of Michigan Medical SchoolClass of 2013
Certifications & Licensure
IL State Medical License 2021 - 2029
MI State Medical License 2013 - 2023
NY State Medical License 2019 - 2021
American Board of Surgery Surgery
Publications & Presentations
PubMed
- 1 citationsUnderstanding what surgical advanced practice providers want: A survey of autonomy, tasks, and training preferences across three institutions.Charlotte L Harrington, Max J Hyman, Nathan J Graham, Christopher P Filson, Susanne A Quallich
American Journal of Surgery. 2026-09-01 - Projected Cancer Screening and Outcomes Under the 2025 Federal Medicaid Eligibility Restrictions.Sarah P Shubeck, Adrian Diaz
JAMA Oncology. 2026-03-01 - 2 citationsAdjuvant Chemotherapy Use for Hormone Receptor-Positive, ERBB2-Negative Breast Cancer After RxPONDER Trial.Jincong Q Freeman, Poornima Saha, Daniel S Peiffer, Nan Chen, Sarah P Shubeck
JAMA Network Open. 2025-12-01
Press Mentions
More Colorectal Cancer Screening Options, More Coverage ProblemsAugust 20th, 2026- What Age Should I Start Having Mammograms? Here Are the Latest RecommendationsOctober 21st, 2024
- What You Need to Know About Breast Cancer — Forms, Treatment, and Disparities Correction Between White and Black Women with Dr. Sarah Shubeck and Dr. Kyra NicholsonJuly 30th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
